These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13740302)

  • 21. Developmental delay in fetal aminopterin/methotrexate syndrome.
    Del Campo M; Kosaki K; Bennett FC; Jones KL
    Teratology; 1999 Jul; 60(1):10-2. PubMed ID: 10413333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A GROWING SPECTRUM FOR THE ANTIMETABOLITES.
    HART GD
    Appl Ther; 1964 Jul; 6():596-8. PubMed ID: 14179437
    [No Abstract]   [Full Text] [Related]  

  • 23. Differing specificities for 4-aminofolate analogues of folylpolyglutamyl synthetase from tumors and proliferative intestinal epithelium of the mouse with significance for selective antitumor action.
    Rumberger BG; Barrueco JR; Sirotnak FM
    Cancer Res; 1990 Aug; 50(15):4639-43. PubMed ID: 2369741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FURTHER OBSERVATIONS OF THE BINDING AND INHIBITION OF DIHYDROFOLIC REDUCTASE BY FOLIC ACID ANTAGONISTS.
    SCHRECKER AW; HUENNEKENS FM
    Biochem Pharmacol; 1964 May; 13():731-42. PubMed ID: 14181276
    [No Abstract]   [Full Text] [Related]  

  • 25. SOME EFFECTS OF FOLIC ACID ANTAGONISTS ON VIRUS INDUCED CHICKEN ERYTHROLEUKAEMIA.
    STENKVIST B; PONTEN J
    Acta Pathol Microbiol Scand; 1964; 61():46-54. PubMed ID: 14150633
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of dihydrofolate reductase from bacterial and vertebrate sources by folate, aminopterin, methotrexate and their 5-deaza analogues.
    Stone SR; Montgomery JA; Morrison JF
    Biochem Pharmacol; 1984 Jan; 33(2):175-9. PubMed ID: 6367748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Folic-acid antagonists in psoriasis.
    Br Med J; 1966 May; 1(5499):1313. PubMed ID: 5934371
    [No Abstract]   [Full Text] [Related]  

  • 28. CLINICAL STUDIES OF DICHLOROMETHOTREXATE (NSC 29630).
    FREI E; SPURR CL; BRINDLEY CO; SELAWRY O; HOLLAND JF; RALL DP; WASSERMAN LR; HOOGSTRATEN B; SHNIDER BI; MCINTYRE OR; MATTHEWS LB; MILLER SP
    Clin Pharmacol Ther; 1965; 6():160-71. PubMed ID: 14288185
    [No Abstract]   [Full Text] [Related]  

  • 29. [Psoriasis. treatment by aminopterin and methotrexate].
    RAVINA A
    Annee Ther; 1962; 33():44-6. PubMed ID: 13990834
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias.
    Norris RE; Adamson PC
    Cancer Chemother Pharmacol; 2010 May; 65(6):1125-30. PubMed ID: 19784838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of folate antagonists on the metabolism of folic acid and its reduced derivatives in rat liver and kidney.
    Bühring U; Shin YS; Fölsch E
    Cancer Res; 1977 Jan; 37(1):299-304. PubMed ID: 830415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase 2B trial of aminopterin in multiagent therapy for children with newly diagnosed acute lymphoblastic leukemia.
    Cole PD; Drachtman RA; Masterson M; Smith AK; Glod J; Zebala JA; Lisi S; Drapala DA; Kamen BA
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):65-75. PubMed ID: 17768625
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Syntheses and antifolate activity of 5-methyl-5-deaza analogues of aminopterin, methotrexate, folic acid, and N10-methylfolic acid.
    Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Sirotnak FM
    J Med Chem; 1986 Jun; 29(6):1080-7. PubMed ID: 2423690
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hydroxylation of 4-amino-antifolates by partially purified aldehyde oxidase from rabbit liver.
    Fabre G; Seither R; Goldman ID
    Biochem Pharmacol; 1986 Apr; 35(8):1325-30. PubMed ID: 2421732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant therapy of choriocarcinoma with methotrexate.
    PERLSON SG; WHITSITT RE
    Obstet Gynecol; 1960 Feb; 15():175-81. PubMed ID: 14431905
    [No Abstract]   [Full Text] [Related]  

  • 36. Antimetabolite-metabolite cancer chemotherapy using continuous intra-arterial methotrexate with intermittent intramuscular citrovorum factor. Method of therapy.
    DUFF JK; SULLIVAN RD; MILLER E; ULM AH; CLARKSON BD; CLIFFORD P
    Cancer; 1961; 14():744-52. PubMed ID: 13724783
    [No Abstract]   [Full Text] [Related]  

  • 37. Activity of sulfa drugs and dihydrofolate reductase inhibitors against Candida albicans.
    Bush K; Freudenberger JS; Slusarchyk DS; Sykes RB; Meyers E
    Experientia; 1982 Apr; 38(4):436-7. PubMed ID: 7044814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of methotrexate in secondary chorionepithelioma; report of a case.
    MANLY GA
    J Obstet Gynaecol Br Commonw; 1961 Apr; 68():277-9. PubMed ID: 13766195
    [No Abstract]   [Full Text] [Related]  

  • 39. Reactivation of dihydrofolate reductase inhibted by methotrexate or aminopterin.
    Jackson RC; Niethammer D; Hart LI
    Arch Biochem Biophys; 1977 Aug; 182(2):646-56. PubMed ID: 561567
    [No Abstract]   [Full Text] [Related]  

  • 40. Antimetabolite-metabolite combination cancer chemotherapy. Effects of intraarterial methotrexate-intramuscular Citrovorum factor therapy in human cancer.
    SULLIVAN RD; MILLER E; SIKES MP
    Cancer; 1959; 12():1248-62. PubMed ID: 13835650
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.